scorecardresearch
Add as a preferred source on Google
Friday, May 1, 2026
TopicVaccine patent

Topic: Vaccine patent

After filing for Covaxin patent solo, Bharat Biotech to add ICMR as co-inventor

Hyderabad-based vaccine maker says not including ICMR in original patent application for Covaxin was ‘inadvertent error’ & ‘confidential agreement between them was not accessible’.

G7 focus on China a breather for Modi’s India. But questions on Covid drugs won’t go away

G7 diplomats are now echoing the Supreme Court of India — why hasn't the Modi govt granted compulsory licences to pharma companies to at least manufacture anti-Covid drugs if not vaccines.

BRICS with a Capital C: How Covid robbed members of economic advantage

Vaccine manufacturers China and Russia never came forward to share the formula with or waive IPR for other BRICS members. So much for the cooperation in the Covid fight.

Covid vaccine patents can be waived without hurting firms like Bharat Biotech. Here’s how

It is time countries acted with a humanitarian approach at WTO and relaxed IPR provisions for Covid-19 vaccines. And it can be done without disincentivising R&D efforts.

India’s vaccine diplomacy is falling apart. Why PM Modi can’t convince EU to waive patents

While Modi waxed eloquent on India-EU trade talks, European leaders were unhappy at US for supporting Delhi's demand to waive Covid vaccine patents.

Why the TRIPS waiver is unlikely to solve India’s Covid-19 vaccine shortage

Instead of trying to obtain an IP waiver, the govt must enable vaccine manufacturers to expand production & reduce inefficiencies in procurement & distribution.

With ‘Gandhi’ and ‘Nehru’ in his cabinet, Stalin has a historical burden to shake off

ThePrint view on the most important issues, instantly.

Now, it’s over to the WTO to clinch a deal on vaccine patent waivers

India and South Africa have proposed a broad waiver from the Trips agreement’s rules on the production and export of vaccines needed to combat the Covid-19 virus.

Now is not the time to hanker for patents. WTO must waive IP rights on Covid vaccines

US, EU, Canada and other developed nations, with access to Covid-19 vaccines, must stop opposing India and South Africa's proposal to waive patent and intellectual property rights.

On Camera

India’s workforce is stuck in low productivity. Here’s what must change

India’s workforce continues to exhibit disproportionate concentration in agriculture and self-employment, and limited expansion in salaried work.

Adani’s giant copper plant hits technical setbacks in first year

The 500,000 tonne-per-year plant produced just 94,000 tonnes of refined copper from April 2025 to February this year.

76 yrs on, exhibition on Korean War brings to life independent India’s 1st overseas military deployment

'Guardians of Neutrality: India's Korean Mission', organised in Delhi, brought out unknown and forgotten aspects of the war.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.